Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency

作者: Qiliang Cai , Subhash C. Verma , Ji-Young Choi , Michelle Ma , Erle S. Robertson

DOI: 10.1128/JVI.01293-10

关键词: GammaherpesvirinaeCytokineInterleukin 4Cancer researchSignal transductionPrimary effusion lymphomaKaposi's sarcoma-associated herpesvirusBiologyVirus latencyImmune system

摘要: Cytokine-mediated JAK/STAT signaling controls numerous important biologic responses like immune function, cellular growth, and differentiation. Inappropriate activation of this pathway is associated with a range malignancies. Kaposi's sarcoma-associated herpesvirus (KSHV) the infectious viral agent sarcoma may also contribute to B-cell disorders, which include primary effusion lymphoma (PEL) multicentric Castleman's disease. However, regulation cytokine-mediated lymphocytic response by KSHV not fully understood. In report, we demonstrate that suppresses interleukin-4 (IL-4)-stimulated B-lymphocyte cell proliferation. Moreover, show latency-associated nuclear antigen (LANA) encoded essential for blocking IL-4-induced signaling. LANA reduces phosphorylation signal transducers activators transcription 6 (STAT6) on Y-641 concomitantly its DNA binding ability. Importantly, knockdown endogenous STAT6 dramatically increases sensitivity PEL cells low-serum stress or chemical-mediated apoptosis reactivation from latent replication. Thus, these findings suggest IL-4/STAT6 network precisely controlled survival, maintenance latency, suppression host cytokine virus-infected cells.

参考文章(68)
L Rainbow, G M Platt, G R Simpson, R Sarid, S J Gao, H Stoiber, C S Herrington, P S Moore, T F Schulz, The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. Journal of Virology. ,vol. 71, pp. 5915- 5921 ,(1997) , 10.1128/JVI.71.8.5915-5921.1997
Johan Thyberg, Eva Severinson, Daniel H. Conrad, Edward J. Davey, Regulation of Cell Morphology in B Lymphocytes by IL-4: Evidence for Induced Cytoskeletal Changes Journal of Immunology. ,vol. 160, pp. 5366- 5373 ,(1998)
Xiuying Chen, Lin Cheng, Xuemei Jia, Yi Zeng, Shuihong Yao, Zhigang Lv, Di Qin, Xin Fang, Yongliang Lei, Chun Lu, Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia. ,vol. 11, pp. 1272- 1284 ,(2009) , 10.1593/NEO.09494
S. M. Wellicome, M. H. Thornhill, J. S. S. Lanchbury, U. Kyan-Aung, D. L. Mahiouz, D. O. Haskard, Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. Journal of Immunology. ,vol. 146, pp. 592- 598 ,(1991)
G Huston, S L Swain, A D Weinberg, M English, IL-4 directs the development of Th2-like helper effectors. Journal of Immunology. ,vol. 145, pp. 3796- 3806 ,(1990)
Jacques Friborg, Wing-pui Kong, Michael O. Hottiger, Gary J. Nabel, p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. ,vol. 402, pp. 889- 894 ,(1999) , 10.1038/47266
Simon Talbot, P Kellam, R A Weiss, D Whitby, S Matthews, C Boshoff, Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. Journal of Human Virology. ,vol. 1, pp. 19- 29 ,(1997)
D F Mangan, B Robertson, S M Wahl, IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. Journal of Immunology. ,vol. 148, pp. 1812- 1816 ,(1992)
Mingsheng Zhang, Yunfeng Zhou, Conghua Xie, Fuxiang Zhou, Yun Chen, Guang Han, Wen Jie Zhang, STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells. Cancer Letters. ,vol. 243, pp. 38- 46 ,(2006) , 10.1016/J.CANLET.2005.11.020